<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20693" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Down Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Akhtar</surname>
            <given-names>Faisal</given-names>
          </name>
          <aff>Ochsner Health Systems</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bokhari</surname>
            <given-names>Syed Rizwan A.</given-names>
          </name>
          <aff>Tulane Un, Un Med Center New Orleans</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faisal Akhtar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Syed Rizwan Bokhari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20693.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Down syndrome (trisomy 21) is a genetic disorder caused by the presence of all or a portion of a third chromosome 21. Patients typically present with mild to moderate intellectual disability, growth retardation, and characteristic facial features. This activity reviews the evaluation and management of Down syndrome and explains the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology of Down syndrome.</p></list-item><list-item><p>Identify atrial septal defects as the most common cardiac abnormalities in patients with Down syndrome.</p></list-item><list-item><p>Summarize the use of ultrasound, amniocentesis, and chorionic villus sampling in the prenatal diagnosis of Down syndrome.</p></list-item><list-item><p>Outline the importance of collaboration and communication among the interprofessional team to enhance the delivery of care and improve outcomes for patients affected by Down syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20693&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20693">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20693.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Down syndrome was first described by an English physician, John Langdon Down, in 1866, but its association with chromosome 21 was established almost 100 years later by Dr. Jerome Lejeune in Paris. It is the presence of&#x000a0;all or part of the third copy of chromosome 21 that causes Down syndrome, the most common chromosomal abnormality occurring in humans.<xref ref-type="bibr" rid="article-20693.r1">[1]</xref>&#x000a0;It is also found that the most frequently occurring live-born aneuploidy is trisomy 21, which causes this syndrome.<xref ref-type="bibr" rid="article-20693.r2">[2]</xref></p>
      </sec>
      <sec id="article-20693.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The majority of patients with Down syndrome have an extra copy of chromosome 21. There are different hypotheses related to the genetic basis of Down syndrome and the association of different genotypes with the phenotypes. Among them is gene dosage imbalance, in which there is an increased dosage or number of genes of Hsa21, which results in increased gene expansion.<xref ref-type="bibr" rid="article-20693.r3">[3]</xref>. It further includes the possibility of association of different genes with different phenotypes of Down syndrome. The other popular hypothesis is the amplified development instability hypothesis, according to which the genetic imbalance created by a number of trisomic genes results in a greater impact on the expression and regulation of many genes.<xref ref-type="bibr" rid="article-20693.r3">[3]</xref></p>
        <p>The critical region hypothesis is also well-known in this list. Down syndrome critical regions (DSCR) are a few chromosomal regions that are associated with partial trisomy for Has21. DSCR on 21q21.22 is responsible for many clinical features of Down syndrome.<xref ref-type="bibr" rid="article-20693.r3">[3]</xref><xref ref-type="bibr" rid="article-20693.r4">[4]</xref>&#x000a0;After a thorough study of different analyses, it became clear that&#x000a0;a single critical region gene cannot cause all the phenotypical features associated with trisomy 21,&#x000a0;rather it is more evident that multiple critical regions or critical genes have a role to play in this phenomenon.<xref ref-type="bibr" rid="article-20693.r5">[5]</xref></p>
      </sec>
      <sec id="article-20693.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of Down syndrome increases with maternal age, and its occurrence varies in different populations (1 in 319 to 1 in 1000 live births)<xref ref-type="bibr" rid="article-20693.r6">[6]</xref><xref ref-type="bibr" rid="article-20693.r7">[7]</xref>. It&#x000a0;is also known that&#x000a0;the frequency of Down syndrome fetuses is quite&#x000a0;high at the time of conception, but about 50% to 75% of these fetuses are lost before term. The occurrence of other autosomal trisomy is much more common than the 21, but the postnatal survival is very poor&#x000a0;as compared to Down syndrome. This high percentage of survival of patients with trisomy 21 is thought to be a function of a small number of genes on chromosome 21 called Hsa21, which is the smallest and least dense of the autosomes.<xref ref-type="bibr" rid="article-20693.r8">[8]</xref></p>
      </sec>
      <sec id="article-20693.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>An extra copy of chromosome 21 is associated with Down syndrome, which occurs due to the failure of chromosome 21 to separate during gametogenesis, resulting in an extra chromosome in all the body cells. Robertsonian translocation and isochromosome&#x000a0;or ring chromosome are the other 2 possible&#x000a0;causes of trisomy 21. Isochromosome is a condition when 2 long arms separate together instead of the long and short arms while in Robertsonian translocation. This&#x000a0;occurs in 2% to 4% of the patients. The long arm of chromosome 21 is attached to another chromosome, mostly chromosome 14. In mosaicism, there are 2 different cell lines because of the error of division after fertilization.<xref ref-type="bibr" rid="article-20693.r6">[6]</xref></p>
      </sec>
      <sec id="article-20693.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Clinical Features</bold>
</p>
        <p>Different clinical conditions are associated with Down syndrome as different systems are affected by it. These patients have a wide array of signs and symptoms like intellectual and developmental disabilities or neurological features, congenital heart defects, gastrointestinal (GI) abnormalities, characteristic facial features, and abnormalities.<xref ref-type="bibr" rid="article-20693.r9">[9]</xref></p>
        <p>
<bold>Congenital Cardiac Defects (CHD)</bold>
</p>
        <p>Congenital cardiac defects are by far the most common and leading cause associated with morbidity and mortality in patients with Down syndrome, especially in the first 2 years of life. Though different suggestions have been&#x000a0;made about the geographical as well as seasonal variation in the occurrence of different types of&#x000a0;congenital cardiac defects in trisomy 21,&#x000a0;so far none of the results have been conclusive.<xref ref-type="bibr" rid="article-20693.r10">[10]</xref></p>
        <p>The incidence of CHD in babies born with Down syndrome is up to 50%. The most common cardiac defect associated with Down syndrome is an atrioventricular septal defect (AVSD), and this defect makes up to 40% of the congenital cardiac defects in Down syndrome.<xref ref-type="bibr" rid="article-20693.r6">[6]</xref>&#x000a0;It is said to be associated with the mutation of the non-Hsa21 CRELD1 gene<xref ref-type="bibr" rid="article-20693.r6">[6]</xref><xref ref-type="bibr" rid="article-20693.r11">[11]</xref>&#x000a0;The second most common cardiac defect in Down syndrome is a ventricular septal defect (VSD), which is seen in about 32% of the patients with Down syndrome. Together with AVSD, these account for more than 50% of congenital cardiac defects in patients with Down syndrome.<xref ref-type="bibr" rid="article-20693.r6">[6]</xref><xref ref-type="bibr" rid="article-20693.r11">[11]</xref></p>
        <p>The other cardiac defects associated with trisomy 21 are secundum atrial defect (10%), tetralogy of Fallot (6%), and isolated PDA (4%), while about 30% of the patients have more than one cardiac defect. There is geographical variation in the prevalence of the cardiac defect in Down syndrome, with VSD being the most common in Asia and secundum type ASD in Latin America. The reason behind this difference in the prevalence of different types of&#x000a0;CHD in different regions is still unclear, and many factors such as&#x000a0;regional proximity have been found to contribute.<xref ref-type="bibr" rid="article-20693.r6">[6]</xref></p>
        <p>Because of such a high prevalence of CHD in patients with Down syndrome, it has been recommended that all patients get an echocardiogram within the first few weeks of life.</p>
        <p>
<bold>Gastrointestinal (GI) Tract Abnormalities</bold>
</p>
        <p>Patients with trisomy 21 have many structural and functional disorders related to the GI tract. Structural defects can occur anywhere from the mouth to anus, and it has been found that certain defects like duodenal and small bowel atresia or stenosis, annular pancreas, imperforate anus, and Hirschsprung disease occur more commonly in these patients as compared to the general population.<xref ref-type="bibr" rid="article-20693.r1">[1]</xref></p>
        <p>About 2% of patients with Down syndrome have Hirschsprung disease while 12% of patients with&#x000a0;Hirschsprung disease&#x000a0;have&#x000a0;Down syndrome.<xref ref-type="bibr" rid="article-20693.r1">[1]</xref><xref ref-type="bibr" rid="article-20693.r6">[6]</xref>&#x000a0;Hirschsprung disease&#x000a0;is a form of&#x000a0;functional lower intestinal obstruction in which the neural cells fail to migrate to the distal segment of the rectum resulting in an aganglionic segment which does not have normal peristalsis resulting in failure of normal defecation reflex causing a functional obstruction.<xref ref-type="bibr" rid="article-20693.r12">[12]</xref>&#x000a0;The infant usually presents with signs and symptoms related to intestinal obstruction. Duodenal atresia and imperforate anus usually present in the neonatal period.</p>
        <p>Apart from the structural defects patients with Down syndrome, patients are also prone to many other GI disorders like gastroesophageal reflux (GERD), chronic constipation, intermittent diarrhea, and celiac disease. Since there is a strong association of celiac disease with Down syndrome being present in about 5% of these patients, it is recommended to do yearly screening of celiac disease. Once diagnosed, these patients will have to remain on a gluten-free diet for the rest of life.<xref ref-type="bibr" rid="article-20693.r13">[13]</xref></p>
        <p>
<bold>Hematologic Disorders</bold>
</p>
        <p>There are several hematological disorders associated with Down syndrome. The hematological abnormalities in a newborn with Down syndrome (HANDS) constitute neutrophilia, thrombocytopenia, and polycythemia, which are seen in 80%, 66% and 34% of Down syndrome babies respectively.<xref ref-type="bibr" rid="article-20693.r14">[14]</xref><xref ref-type="bibr" rid="article-20693.r15">[15]</xref><xref ref-type="bibr" rid="article-20693.r16">[16]</xref>&#x000a0;HANDS is usually mild and resolves within the first thr3e weeks of life.<xref ref-type="bibr" rid="article-20693.r14">[14]</xref><xref ref-type="bibr" rid="article-20693.r15">[15]</xref><xref ref-type="bibr" rid="article-20693.r16">[16]</xref></p>
        <p>The other disorder that is quite&#x000a0;specific to Down syndrome is a transient myeloproliferative disorder, which is defined as detection of blast cells in younger than 3 month old babies with Down syndrome. It is characterized by the clonal proliferation of megakaryocytes and is detected during the first week of life and is resolved by 3 months of life. It is also known as transient abnormal myelopoiesis or transient leukemia and is known to be present in about 10% of patients with Down syndrome. If this occurs in the fetus, it can cause spontaneous abortion.<xref ref-type="bibr" rid="article-20693.r17">[17]</xref><xref ref-type="bibr" rid="article-20693.r18">[18]</xref></p>
        <p>Patients with Down syndrome are 10-times more at risk of developing leukemia,<xref ref-type="bibr" rid="article-20693.r19">[19]</xref>&#x000a0;which constitute about 2% of all pediatric acute lymphoblastic leukemia and 10% of all pediatric acute myeloid leukemia. Thirty percent of Down syndrome patients with acute lymphoblastic leukemia have an association with function mutation in Janus Kinase 2 gene.<xref ref-type="bibr" rid="article-20693.r20">[20]</xref></p>
        <p>About 10% of patients with chronic myeloid leukemia (TML) develop leukemogenesis of acute megakaryoblastic leukemia (AMKL) before the age of 4 years. AMKL is associated with GATA1 gene which is an X-linked transcriptor factor leading to an uncontrolled proliferation of immature megakaryocytes.<xref ref-type="bibr" rid="article-20693.r21">[21]</xref></p>
        <p>
<bold>Neurologic Disorders</bold>
</p>
        <p>Trisomy of Hsa21 has associated with reduced brain volume especially hippocampus and cerebellum.<xref ref-type="bibr" rid="article-20693.r22">[22]</xref>&#x000a0;Hypotonia is the hallmark of babies with Down syndrome and is present in almost all of them. It is defined as decreased resistance to passive muscle stretch and is responsible for delayed motor development in these patients.<xref ref-type="bibr" rid="article-20693.r23">[23]</xref>.&#x000a0;Because of hypotonia Down syndrome patients have joint laxity that causes decreased gait stability and increased energy requirement for physical exertion.<xref ref-type="bibr" rid="article-20693.r24">[24]</xref>.&#x000a0;These patients are prone to decreased bone mass and increased risk of fractures due to the low level of physical activity<xref ref-type="bibr" rid="article-20693.r25">[25]</xref>,&#x000a0;while the ligamentous laxity predisposes these patients to atlantoaxial subluxation.<xref ref-type="bibr" rid="article-20693.r26">[26]</xref></p>
        <p>Five&#x000a0;percent to 13% of children with Down syndrome have seizures<xref ref-type="bibr" rid="article-20693.r27">[27]</xref>,&#x000a0;out of that, 40% will have seizures before their first birthday, and in these cases, the seizures are usually infantile spasms.<xref ref-type="bibr" rid="article-20693.r28">[28]</xref>&#x000a0;Down syndrome children with infantile spasm do&#x000a0;respond better to antiepileptics as compared to other kids with the same, and therefore, early intervention and treatment improve the developmental outcome.<xref ref-type="bibr" rid="article-20693.r27">[27]</xref></p>
        <p>Lennox-Gestaut syndrome is also seen to be more prevalent in children with Down syndrome when it does occur, has a late onset, and is associated with reflex seizures along with an increased rate of EEG abnormalities.<xref ref-type="bibr" rid="article-20693.r29">[29]</xref></p>
        <p>Forty percent of patients with Down syndrome develop&#x000a0;tonic-clonic or myoclonic&#x000a0;seizures in their first 3 decades.<xref ref-type="bibr" rid="article-20693.r28">[28]</xref>&#x000a0;Dementia occurs more commonly in patients older than 45 years of age with Down syndrome<xref ref-type="bibr" rid="article-20693.r30">[30]</xref>,&#x000a0;and about 84% are more prone to develop seizures.<xref ref-type="bibr" rid="article-20693.r31">[31]</xref>&#x000a0;The seizures in these patients are related to the rapid decline in their cognitive functions.<xref ref-type="bibr" rid="article-20693.r32">[32]</xref></p>
        <p>The risk of developing early-onset Alzheimer disease is significantly&#x000a0;high in patients with Down syndrome with 50% to 70% of patients developing dementia by the age of 60 years.<xref ref-type="bibr" rid="article-20693.r33">[33]</xref>&#x000a0;Amyloid precursor protein (APP), which is known to be associated with&#x000a0;increased risk for the&#x000a0;Alzheimer disease&#x000a0;is found to be encoded on Hsa21, and trisomy of this protein is likely to be responsible for increased frequency of dementia in people with Down syndrome. Recent studies have shown that triplication of APP is associated with increased risk of early-onset&#x000a0;Alzheimer disease&#x000a0;even in the normal population.<xref ref-type="bibr" rid="article-20693.r34">[34]</xref></p>
        <p>Nearly all the patients with Down syndrome have mild to moderate learning disability. Trisomy of multiple genes including DYRK1A, synaptojanin 1, and single-minded homolog 2 (SIM2) have been found to cause learning and memory defects in mice, which suggests the&#x000a0;possibility that the overexpression of these genes may likely be causing the learning disability in people with Down syndrome.<xref ref-type="bibr" rid="article-20693.r35">[35]</xref></p>
        <p>
<bold>Endocrinological Disorders</bold>
</p>
        <p>Thyroid gland dysfunction is most commonly associated with Down syndrome. Hypothyroidism can be congenital or acquired at any time&#x000a0;during life.<xref ref-type="bibr" rid="article-20693.r25">[25]</xref>&#x000a0;The newborn screening program in New York has reported an increased incidence of congenital hypothyroidism in babies with Down syndrome as compared to the others.<xref ref-type="bibr" rid="article-20693.r36">[36]</xref>&#x000a0;The anti-thyroid autoantibodies were found in 13% to 34% of patients with Down syndrome who had acquired hypothyroidism, and the concentration of these antibodies increased after 8 years of life.<xref ref-type="bibr" rid="article-20693.r25">[25]</xref>.&#x000a0;About half of the patients with Down syndrome have been shown to have subclinical hypothyroidism with elevated TSH and normal thyroxine levels.<xref ref-type="bibr" rid="article-20693.r37">[37]</xref>&#x000a0;Hyperthyroidism is much less frequent in patients with Down syndrome as compared to hypothyroidism, although the rate of it still exceeds the incidence of hyperthyroidism in the general pediatric population.<xref ref-type="bibr" rid="article-20693.r38">[38]</xref></p>
        <p>Abnormalities in sexual development are also noted to be significant with delayed puberty in both genders. In girls, primary hypogonadism presents as delay in menarche or adrenarche, while in boys it can manifest as cryptorchidism, ambiguous genitalia, micropenis, small testes, low sperm count, and scanty growth of axillary and pubic hair.<xref ref-type="bibr" rid="article-20693.r25">[25]</xref></p>
        <p>&#x000a0;The insulin-like growth factor is also said to be responsible for the delay in skeletal maturation and short stature in patients with Down syndrome.<xref ref-type="bibr" rid="article-20693.r25">[25]</xref></p>
        <p>
<bold>Musculoskeletal Disorders</bold>
</p>
        <p>Children with Down syndrome are at an increased risk of reduced muscle mass because of hypotonia increased ligamentous laxity which causes retardation of gross motor skills and can result in joint dislocation.<xref ref-type="bibr" rid="article-20693.r39">[39]</xref>&#x000a0;These patients also have vitamin D deficiency due to several factors like inadequate exposure to sunlight, inadequate intake of vitamin D, malabsorption secondary to celiac disease, increased breakdown because of anticonvulsant therapy, among other factors. These factors increase the risk of decreased bone mass in children with Down syndrome and predispose them to recurrent fractures.<xref ref-type="bibr" rid="article-20693.r40">[40]</xref></p>
        <p>
<bold>Refractive Errors and Visual Abnormalities</bold>
</p>
        <p>Ocular and orbital anomalies are common in children with&#x000a0;Down syndrome. These include blepharitis (2-7%), keratoconus (5-8%), cataract (25% to 85%), retinal anomalies (0% to 38%), strabismus (23% to 44%), amblyopia (10% to 26%), nystagmus (5% to 30%), refractive errors (18% to 58%), glaucoma (less than 1%), iris anomalies (38% to 90%) and optic nerve anomalies (very few cases).</p>
        <p>The ocular anomalies, if left untreated, can significantly affect the lives of these patients. Therefore, all the patients with&#x000a0;Down syndrome&#x000a0;should have an eye exam is done during the first 6 months of life and then annually.<xref ref-type="bibr" rid="article-20693.r41">[41]</xref></p>
        <p>
<bold>Otorhinolaryngological (</bold>
<bold>ENT)&#x000a0;Disorders</bold>
</p>
        <p>Ear, nose, and throat problems are also quite&#x000a0;common in patients with&#x000a0;Down syndrome. The anatomical structure of the ear in&#x000a0;Down syndrome&#x000a0;patients predisposes them to&#x000a0;hearing&#x000a0;deficits. Hearing loss is usually conductive because of impaction of cerumen and middle ear pathologies, including chronic middle ear effusion due to the small Eustachian tube, acute otitis media, and eardrum perforation. These patients usually require pressure equalization tubes for the treatment.</p>
        <p>The sensorineural&#x000a0;hearing loss has also been associated with&#x000a0;Down syndrome&#x000a0;because of the structural abnormalities in the inner ears such as narrow internal auditory canals.<xref ref-type="bibr" rid="article-20693.r42">[42]</xref></p>
      </sec>
      <sec id="article-20693.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>There are different methods used for the prenatal diagnosis of Down syndrome. Ultrasound, between 14 and 24 weeks of gestation, can be used as a tool for diagnosis based on soft markers like increased nuchal fold thickness, small or no nasal bone, and large ventricles.<xref ref-type="bibr" rid="article-20693.r43">[43]</xref>&#x000a0;Nuchal translucency (NT) is detected by ultrasound and is caused by a collection of fluid under the skin behind the fetal neck. It is done between 11 and 14 weeks of gestation. Other causes of this finding include Other causes are trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome), and Turner syndrome. Amniocentesis and chorionic villus sampling have widely been used for the diagnosis, but there is a small risk of miscarriages between 0.5% to 1%.<xref ref-type="bibr" rid="article-20693.r44">[44]</xref></p>
        <p>Several other methods have also been developed and are used for the rapid detection of trisomy 21 both during fetal life and after birth. The FISH of interphase nuclei is most commonly used by either using Hsa21-specific probes or the whole of the Hsa21.<xref ref-type="bibr" rid="article-20693.r45">[45]</xref>&#x000a0;Another method that is currently being used is QF-PCR, in which the presence of 3 different alleles is determined by using DNA polymorphic markers.<xref ref-type="bibr" rid="article-20693.r46">[46]</xref>&#x000a0;The success of this method depends upon the informative markers and the presence of&#x000a0;DNA. It has been found that up to 86.67% of cases of Down syndrome can be identified by using the STR marker method.<xref ref-type="bibr" rid="article-20693.r47">[47]</xref></p>
        <p>A relatively new method called paralogue sequence quantification (PSQ) uses the paralogue sequence on the Hsa21 copy number. It is a PCR-based method that uses the paralogue genes to detect the targeted chromosome number abnormalities, which is known as paralogue sequence quantification.<xref ref-type="bibr" rid="article-20693.r48">[48]</xref></p>
        <p>There are non-invasive prenatal diagnostic methods that are being studied to be used for the diagnosis of Down syndrome&#x000a0;prenatally. These are based on the presence of fetal cells in the maternal blood and the presence of&#x000a0;cell-free fetal DNA in the maternal serum. <xref ref-type="bibr" rid="article-20693.r49">[49]</xref></p>
        <p>Cell-free fetal DNA makes up 5% to 10% of the maternal plasma, and it increases during pregnancy and clears after delivery. Though this method has been used to determine fetal Rh status in Rhive women<xref ref-type="bibr" rid="article-20693.r50">[50]</xref>,&#x000a0;sex in sex-linked disorders<xref ref-type="bibr" rid="article-20693.r51">[51]</xref>,&#x000a0;and for the detection of paternally inherited autosomal recessive and dominant traits,<xref ref-type="bibr" rid="article-20693.r52">[52]</xref>&#x000a0;its use for the detection of chromosomal aneuploidy, especially the trisomy is still a challenge.</p>
        <p>Few other recent methods like digital PCR and next-generation sequencing (NGS) are also being developed for the diagnosis of Down syndrome.<xref ref-type="bibr" rid="article-20693.r53">[53]</xref></p>
      </sec>
      <sec id="article-20693.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of patients with Down syndrome is multidisciplinary. Newborns with suspicion of Down syndrome should have a karyotyping done to confirm the diagnosis. The family needs to be referred to the clinical geneticist for the genetic testing and counseling of both parents.</p>
        <p>Parental education is one of the foremost aspects regarding the management of Down syndrome, as parents need to be aware of the different possible&#x000a0;conditions associated with it so that&#x000a0;they can be diagnosed and treated appropriately. Treatment is basically symptomatic, and complete recovery is not possible.</p>
        <p>These patients should have their hearing and vision assessed, and as they are more prone to have cataracts, timely surgery is required. Thyroid function tests should be done on a yearly basis and, if deranged, should be managed accordingly.</p>
        <p>A balanced diet, regular exercise,&#x000a0;and&#x000a0;physical therapy are needed for optimum growth and weight gain, although feeding problems improve after cardiac surgery.</p>
        <p>Cardiac referral should arranged for all the patients regardless of the clinical signs of congenital heart disease. If present, this should be corrected within the first&#x000a0;6 months of life to ensure optimum growth and development of the child.</p>
        <p>Other specialties involved include a developmental pediatrician, pediatric pulmonologist, gastroenterologist, neurologist, neurosurgeon, orthopedic specialist, child psychiatrist, physical and occupational therapist, speech and language therapist, and audiologist.</p>
      </sec>
      <sec id="article-20693.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Congenital hypothyroidism</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Mosaic trisomy 21 syndrome</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Partial trisomy 21(or 21q duplication)</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Robertsonian trisomy 21</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Trisomy 18</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Zellweger syndrome or other peroxisomal disorders</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20693.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>With the recent advances in the medical practice, development of surgical techniques for the correction of congenital disabilities, and improvement in general care, there has been a tremendous increase in the survival of infants and life expectancy of patients with Down syndrome. A&#x000a0;Birmingham (United Kingdom) study done almost 60 years ago&#x000a0;showed that 45% of infants survived the first year of life, and only 40% would be alive at 5 years.<xref ref-type="bibr" rid="article-20693.r54">[54]</xref>&#x000a0;A later study conducted about 50 years after that showed that 78% of patients with Down syndrome&#x000a0;plus a congenital heart defect survived for 1 year, while the number went up to 96% in patients without the anomalies.<xref ref-type="bibr" rid="article-20693.r55">[55]</xref>&#x000a0;This rise in the life expectancy of these patients should&#x000a0;continue to rise significantly because of the developments in medical science. Healthcare facilities aim to provide proper and timely management to these patients and to help them to&#x000a0;have a fulfilled and productive life.<xref ref-type="bibr" rid="article-20693.r56">[56]</xref></p>
      </sec>
      <sec id="article-20693.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of patients with Down syndrome is an interprofessional endeavor. Newborns with suspicion of Down syndrome should have a karyotyping done to confirm the diagnosis. The family needs to be referred to the clinical geneticist for the genetic testing and counseling of both parents.</p>
        <p>Because almost every organ system is involved, the child needs to be seen by the ophthalmologist, orthopedic surgeon, cardiologist, dermatologist, gastroenterologist, physical therapist, mental health nurse, ENT surgeon, and behavior specialist.</p>
        <p>Parental education is one of the foremost aspects regarding the management of Down syndrome, as parents need to be aware of the different possible&#x000a0;conditions associated with it so that&#x000a0;they can be diagnosed and treated appropriately. Treatment is basically symptomatic, and complete recovery is not possible.</p>
        <p>While life span has increased over the past 3 decades, these individuals still have a shorter life expectancy compared to healthy individuals.</p>
      </sec>
      <sec id="article-20693.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20693&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20693">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/down-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20693">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20693/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20693">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20693.s13">
        <fig id="article-20693.image.f1" position="float" orientation="portrait">
          <caption>
            <p>A cropped photo of the eyes of a baby with Down Syndrome. Brushfield spots are visible between the inner and outer circle of the iris. Contributed by Wikimedia Commons, Szymon Tomczak (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Brushfield_eye_crop" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-20693.s14">
        <fig id="article-20693.image.f2" position="float" orientation="portrait">
          <caption>
            <p>"This photograph depicts a newborn with the genetic disorder Down Syndrome, due to the presence of an extra 21st chromosome." Contributed by The Centers for Disease Control and Prevention -- ID# 2634/Dr. Godfrey P. Oakley (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Newborn_with_Down_Syndrome" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-20693.s15">
        <fig id="article-20693.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Karyotype for trisomy Down syndrome: Notice the three copies of chromosome 21 Contributed by The National Human Genome Research Institute, Human Genome Project</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Down_Syndrome_Karyotype" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-20693.s16">
        <fig id="article-20693.image.f4" position="float" orientation="portrait">
          <caption>
            <p>A drawing of the facial features of Down syndrome Contributed by the Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities (Public Domain)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Down_syndrome_lg" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20693.s17">
        <title>References</title>
        <ref id="article-20693.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holmes</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Gastrointestinal disorders in Down syndrome.</article-title>
            <source>Gastroenterol Hepatol Bed Bench</source>
            <year>2014</year>
            <season>Winter</season>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <page-range>6-8</page-range>
            <pub-id pub-id-type="pmid">25436092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gardiner</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Herault</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lott</surname>
                <given-names>IT</given-names>
              </name>
              <name>
                <surname>Antonarakis</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Dierssen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Down syndrome: from understanding the neurobiology to therapy.</article-title>
            <source>J Neurosci</source>
            <year>2010</year>
            <month>Nov</month>
            <day>10</day>
            <volume>30</volume>
            <issue>45</issue>
            <fpage>14943</fpage>
            <page-range>14943-5</page-range>
            <pub-id pub-id-type="pmid">21068296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antonarakis</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Lyle</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dermitzakis</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Reymond</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Deutsch</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Chromosome 21 and down syndrome: from genomics to pathophysiology.</article-title>
            <source>Nat Rev Genet</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>10</issue>
            <fpage>725</fpage>
            <page-range>725-38</page-range>
            <pub-id pub-id-type="pmid">15510164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pritchard</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kola</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.</article-title>
            <source>J Neural Transm Suppl</source>
            <year>1999</year>
            <volume>57</volume>
            <fpage>293</fpage>
            <page-range>293-303</page-range>
            <pub-id pub-id-type="pmid">10666684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holland</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Hon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huppert</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Incidence and course of dementia in people with Down's syndrome: findings from a population-based study.</article-title>
            <source>J Intellect Disabil Res</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>44 ( Pt 2)</volume>
            <fpage>138</fpage>
            <page-range>138-46</page-range>
            <pub-id pub-id-type="pmid">10898377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muthuswamy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>"Down syndrome: an insight of the disease".</article-title>
            <source>J Biomed Sci</source>
            <year>2015</year>
            <month>Jun</month>
            <day>11</day>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <pub-id pub-id-type="pmid">26062604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bittles</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Glasson</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical, social, and ethical implications of changing life expectancy in Down syndrome.</article-title>
            <source>Dev Med Child Neurol</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>282</fpage>
            <page-range>282-6</page-range>
            <pub-id pub-id-type="pmid">15077706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roper</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Understanding the basis for Down syndrome phenotypes.</article-title>
            <source>PLoS Genet</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>e50</fpage>
            <pub-id pub-id-type="pmid">16596169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Hematopoietic disorders in Down syndrome.</article-title>
            <source>Int J Clin Exp Pathol</source>
            <year>2008</year>
            <month>Jan</month>
            <day>01</day>
            <volume>1</volume>
            <issue>5</issue>
            <fpage>387</fpage>
            <page-range>387-95</page-range>
            <pub-id pub-id-type="pmid">18787621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benhaourech</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Drighil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hammiri</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Congenital heart disease and Down syndrome: various aspects of a confirmed association.</article-title>
            <source>Cardiovasc J Afr</source>
            <year>2016</year>
            <season>Sep/Oct</season>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>287</fpage>
            <page-range>287-290</page-range>
            <pub-id pub-id-type="pmid">27805241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiseman</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Alford</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Tybulewicz</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Down syndrome--recent progress and future prospects.</article-title>
            <source>Hum Mol Genet</source>
            <year>2009</year>
            <month>Apr</month>
            <day>15</day>
            <volume>18</volume>
            <issue>R1</issue>
            <fpage>R75</fpage>
            <page-range>R75-83</page-range>
            <pub-id pub-id-type="pmid">19297404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amiel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sproat-Emison</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Garcia-Barcelo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lantieri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Burzynski</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Borrego</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pelet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Griseri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Antinolo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Pontual</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Clement-Ziza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Munnich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kashuk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Lyonnet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chakravarti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tam</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Ceccherini</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hofstra</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>R</given-names>
              </name>
              <collab>Hirschsprung Disease Consortium</collab>
            </person-group>
            <article-title>Hirschsprung disease, associated syndromes and genetics: a review.</article-title>
            <source>J Med Genet</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-14</page-range>
            <pub-id pub-id-type="pmid">17965226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallace</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Clinical audit of gastrointestinal conditions occurring among adults with Down syndrome attending a specialist clinic.</article-title>
            <source>J Intellect Dev Disabil</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-50</page-range>
            <pub-id pub-id-type="pmid">17365367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henry</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wiedmeier</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system.</article-title>
            <source>Am J Med Genet A</source>
            <year>2007</year>
            <month>Jan</month>
            <day>01</day>
            <volume>143A</volume>
            <issue>1</issue>
            <fpage>42</fpage>
            <page-range>42-50</page-range>
            <pub-id pub-id-type="pmid">17163522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hord</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Gay</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Whitlock</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Thrombocytopenia in neonates with trisomy 21.</article-title>
            <source>Arch Pediatr Adolesc Med</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>149</volume>
            <issue>7</issue>
            <fpage>824</fpage>
            <page-range>824-5</page-range>
            <pub-id pub-id-type="pmid">7795778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cosgriff</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Hematological abnormalities in newborn infants with Down syndrome.</article-title>
            <source>Am J Med Genet</source>
            <year>1983</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>173</fpage>
            <page-range>173-7</page-range>
            <pub-id pub-id-type="pmid">6228141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zipursky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sutherland</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.</article-title>
            <source>Semin Perinatol</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>97</fpage>
            <page-range>97-101</page-range>
            <pub-id pub-id-type="pmid">9190039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zipursky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.</article-title>
            <source>Clin Lab Med</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>157</fpage>
            <page-range>157-67, vii</page-range>
            <pub-id pub-id-type="pmid">10403079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasle</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Clemmensen</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Mikkelsen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Risks of leukaemia and solid tumours in individuals with Down's syndrome.</article-title>
            <source>Lancet</source>
            <year>2000</year>
            <month>Jan</month>
            <day>15</day>
            <volume>355</volume>
            <issue>9199</issue>
            <fpage>165</fpage>
            <page-range>165-9</page-range>
            <pub-id pub-id-type="pmid">10675114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kearney</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gonzalez De Castro</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Procter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Horsley</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Eguchi-Ishimae</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bateman</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chaplin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Kempski</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>So</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Greaves</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia.</article-title>
            <source>Blood</source>
            <year>2009</year>
            <month>Jan</month>
            <day>15</day>
            <volume>113</volume>
            <issue>3</issue>
            <fpage>646</fpage>
            <page-range>646-8</page-range>
            <pub-id pub-id-type="pmid">18927438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wechsler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McDevitt</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Anastasi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Karp</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Le Beau</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Crispino</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.</article-title>
            <source>Nat Genet</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>148</fpage>
            <page-range>148-52</page-range>
            <pub-id pub-id-type="pmid">12172547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pearlson</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Breiter</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Aylward</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Grygorcewicz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Frangou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barta</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Pulsifer</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>MRI brain changes in subjects with Down syndrome with and without dementia.</article-title>
            <source>Dev Med Child Neurol</source>
            <year>1998</year>
            <month>May</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>326</fpage>
            <page-range>326-34</page-range>
            <pub-id pub-id-type="pmid">9630260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lott</surname>
                <given-names>IT</given-names>
              </name>
            </person-group>
            <article-title>Neurological phenotypes for Down syndrome across the life span.</article-title>
            <source>Prog Brain Res</source>
            <year>2012</year>
            <volume>197</volume>
            <fpage>101</fpage>
            <page-range>101-21</page-range>
            <pub-id pub-id-type="pmid">22541290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agiovlasitis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McCubbin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Yun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pavol</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Widrick</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Economy and preferred speed of walking in adults with and without Down syndrome.</article-title>
            <source>Adapt Phys Activ Q</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>118</fpage>
            <page-range>118-30</page-range>
            <pub-id pub-id-type="pmid">19478345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hawli</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nasrallah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>El-Hajj Fuleihan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Endocrine and musculoskeletal abnormalities in patients with Down syndrome.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>6</issue>
            <fpage>327</fpage>
            <page-range>327-34</page-range>
            <pub-id pub-id-type="pmid">19421241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Merrick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ezra</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Josef</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hendel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Steinberg</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wientroub</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Musculoskeletal problems in Down Syndrome European Paediatric Orthopaedic Society Survey: the Israeli sample.</article-title>
            <source>J Pediatr Orthop B</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>185</fpage>
            <page-range>185-92</page-range>
            <pub-id pub-id-type="pmid">10904905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arya</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kabra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gulati</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Epilepsy in children with Down syndrome.</article-title>
            <source>Epileptic Disord</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">21398208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pueschel</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Louis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McKnight</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Seizure disorders in Down syndrome.</article-title>
            <source>Arch Neurol</source>
            <year>1991</year>
            <month>Mar</month>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>318</fpage>
            <page-range>318-20</page-range>
            <pub-id pub-id-type="pmid">1825777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferlazzo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Adjien</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Guerrini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Calarese</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Crespel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Striano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gelisse</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bramanti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>di Bella</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Genton</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Lennox-Gastaut syndrome with late-onset and prominent reflex seizures in trisomy 21 patients.</article-title>
            <source>Epilepsia</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>1587</fpage>
            <page-range>1587-95</page-range>
            <pub-id pub-id-type="pmid">19187280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Men&#x000e9;ndez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Down syndrome, Alzheimer's disease and seizures.</article-title>
            <source>Brain Dev</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>246</fpage>
            <page-range>246-52</page-range>
            <pub-id pub-id-type="pmid">15862185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Simone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Puig</surname>
                <given-names>XS</given-names>
              </name>
              <name>
                <surname>G&#x000e9;lisse</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Crespel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Genton</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer's disease in Down syndrome.</article-title>
            <source>Seizure</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>7</issue>
            <fpage>383</fpage>
            <page-range>383-9</page-range>
            <pub-id pub-id-type="pmid">20598585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lott</surname>
                <given-names>IT</given-names>
              </name>
              <name>
                <surname>Doran</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>VQ</given-names>
              </name>
              <name>
                <surname>Tournay</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Movsesyan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gillen</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Down syndrome and dementia: seizures and cognitive decline.</article-title>
            <source>J Alzheimers Dis</source>
            <year>2012</year>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>177</fpage>
            <page-range>177-85</page-range>
            <pub-id pub-id-type="pmid">22214782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Janicki</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of dementia and impact on intellectual disability services.</article-title>
            <source>Ment Retard</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>276</fpage>
            <page-range>276-88</page-range>
            <pub-id pub-id-type="pmid">10900935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hunter</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Bachman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Granholm</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Minocycline prevents cholinergic loss in a mouse model of Down's syndrome.</article-title>
            <source>Ann Neurol</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>56</volume>
            <issue>5</issue>
            <fpage>675</fpage>
            <page-range>675-88</page-range>
            <pub-id pub-id-type="pmid">15468085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voronov</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Frere</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Giovedi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pollina</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Borel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Akeson</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Wenk</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Cimasoni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arancio</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Davisson</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Antonarakis</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Gardiner</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>De Camilli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Di Paolo</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2008</year>
            <month>Jul</month>
            <day>08</day>
            <volume>105</volume>
            <issue>27</issue>
            <fpage>9415</fpage>
            <page-range>9415-20</page-range>
            <pub-id pub-id-type="pmid">18591654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haddow</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Palomaki</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Allan</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Gagnon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Heir</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Hermos</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Waisbren</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Faix</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>RZ</given-names>
              </name>
            </person-group>
            <article-title>Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child.</article-title>
            <source>N Engl J Med</source>
            <year>1999</year>
            <month>Aug</month>
            <day>19</day>
            <volume>341</volume>
            <issue>8</issue>
            <fpage>549</fpage>
            <page-range>549-55</page-range>
            <pub-id pub-id-type="pmid">10451459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>T&#x000fc;ys&#x000fc;z</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Beker</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Thyroid dysfunction in children with Down's syndrome.</article-title>
            <source>Acta Paediatr</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>90</volume>
            <issue>12</issue>
            <fpage>1389</fpage>
            <page-range>1389-93</page-range>
            <pub-id pub-id-type="pmid">11853334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lavard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ranl&#x000f8;v</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Perrild</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Jacobsen</surname>
                <given-names>BB</given-names>
              </name>
            </person-group>
            <article-title>Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study.</article-title>
            <source>Eur J Endocrinol</source>
            <year>1994</year>
            <month>Jun</month>
            <volume>130</volume>
            <issue>6</issue>
            <fpage>565</fpage>
            <page-range>565-8</page-range>
            <pub-id pub-id-type="pmid">8205255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morris</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Vaughan</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Vaccaro</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Measurements of neuromuscular tone and strength in Down's syndrome children.</article-title>
            <source>J Ment Defic Res</source>
            <year>1982</year>
            <month>Mar</month>
            <volume>26</volume>
            <issue>Pt 1</issue>
            <fpage>41</fpage>
            <page-range>41-6</page-range>
            <pub-id pub-id-type="pmid">6210779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cabana</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Capone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fritz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berkovitz</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Nutritional rickets in a child with Down syndrome.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>235</fpage>
            <page-range>235-7</page-range>
            <pub-id pub-id-type="pmid">9114996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Merrick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Koslowe</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Refractive errors and visual anomalies in Down syndrome.</article-title>
            <source>Downs Syndr Res Pract</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>131</fpage>
            <page-range>131-3</page-range>
            <pub-id pub-id-type="pmid">11501216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shott</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Down syndrome: common otolaryngologic manifestations.</article-title>
            <source>Am J Med Genet C Semin Med Genet</source>
            <year>2006</year>
            <month>Aug</month>
            <day>15</day>
            <volume>142C</volume>
            <issue>3</issue>
            <fpage>131</fpage>
            <page-range>131-40</page-range>
            <pub-id pub-id-type="pmid">16838306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agathokleous</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chaveeva</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Poon</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Kosinski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nicolaides</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Meta-analysis of second-trimester markers for trisomy 21.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>247</fpage>
            <page-range>247-61</page-range>
            <pub-id pub-id-type="pmid">23208748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Renna</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Pisani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Conversano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Perrone</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Casciaro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Renzo</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Paola</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Perrone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Casciaro</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Sonographic markers for early diagnosis of fetal malformations.</article-title>
            <source>World J Radiol</source>
            <year>2013</year>
            <month>Oct</month>
            <day>28</day>
            <volume>5</volume>
            <issue>10</issue>
            <fpage>356</fpage>
            <page-range>356-71</page-range>
            <pub-id pub-id-type="pmid">24179631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuo</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Tenjin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Segraves</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pinkel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Golbus</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes.</article-title>
            <source>Am J Hum Genet</source>
            <year>1991</year>
            <month>Jul</month>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>112</fpage>
            <page-range>112-9</page-range>
            <pub-id pub-id-type="pmid">2063863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Panigrahi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tamhankar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Phadke</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of Down syndrome and detection of origin of nondisjunction by short tandem repeat analysis.</article-title>
            <source>Genet Test Mol Biomarkers</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>489</fpage>
            <page-range>489-91</page-range>
            <pub-id pub-id-type="pmid">20722466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Panigrahi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Phadke</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Multiplex quantitative fluorescent polymerase chain reaction for detection of aneuploidies.</article-title>
            <source>Genet Test Mol Biomarkers</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>624</fpage>
            <page-range>624-7</page-range>
            <pub-id pub-id-type="pmid">22313045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deutsch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Choudhury</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Merla</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Howald</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sylvan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Antonarakis</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Detection of aneuploidies by paralogous sequence quantification.</article-title>
            <source>J Med Genet</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>41</volume>
            <issue>12</issue>
            <fpage>908</fpage>
            <page-range>908-15</page-range>
            <pub-id pub-id-type="pmid">15591276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walknowska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Conte</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Grumbach</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Practical and theoretical implications of fetal-maternal lymphocyte transfer.</article-title>
            <source>Lancet</source>
            <year>1969</year>
            <month>Jun</month>
            <day>07</day>
            <volume>1</volume>
            <issue>7606</issue>
            <fpage>1119</fpage>
            <page-range>1119-22</page-range>
            <pub-id pub-id-type="pmid">4181601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daniels</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Finning</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects.</article-title>
            <source>Prenat Diagn</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <page-range>101-7</page-range>
            <pub-id pub-id-type="pmid">19085963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lo</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Corbetta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chamberlain</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sargent</surname>
                <given-names>IL</given-names>
              </name>
              <name>
                <surname>Redman</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Wainscoat</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Presence of fetal DNA in maternal plasma and serum.</article-title>
            <source>Lancet</source>
            <year>1997</year>
            <month>Aug</month>
            <day>16</day>
            <volume>350</volume>
            <issue>9076</issue>
            <fpage>485</fpage>
            <page-range>485-7</page-range>
            <pub-id pub-id-type="pmid">9274585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wright</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis.</article-title>
            <source>Hum Reprod Update</source>
            <year>2009</year>
            <season>Jan-Feb</season>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>139</fpage>
            <page-range>139-51</page-range>
            <pub-id pub-id-type="pmid">18945714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voelkerding</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Dames</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Durtschi</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Next-generation sequencing: from basic research to diagnostics.</article-title>
            <source>Clin Chem</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>641</fpage>
            <page-range>641-58</page-range>
            <pub-id pub-id-type="pmid">19246620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>RECORD</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>SMITH</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Incidence, mortality, and dex distribution of mongoloid defectives.</article-title>
            <source>Br J Prev Soc Med</source>
            <year>1955</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-5</page-range>
            <pub-id pub-id-type="pmid">14351707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rankin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Donaldson</surname>
                <given-names>LJ</given-names>
              </name>
              <collab>Northern Congenital Abnormality Survey Steering Group</collab>
            </person-group>
            <article-title>Down's syndrome: occurrence and outcome in the north of England, 1985-99.</article-title>
            <source>Paediatr Perinat Epidemiol</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-9</page-range>
            <pub-id pub-id-type="pmid">12562470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20693.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skotko</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Contributions of a specialty clinic for children and adolescents with Down syndrome.</article-title>
            <source>Am J Med Genet A</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>161A</volume>
            <issue>3</issue>
            <fpage>430</fpage>
            <page-range>430-7</page-range>
            <pub-id pub-id-type="pmid">23401090</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
